Skip to main content
UniHealth

Doctor search

Cynthia Wong, MD

Nephrology · Palo Alto

NPI 1841214376

Medicare standing
Clear
Enrolled, allowed to bill and order, not excluded
Plans that list them
Not verified
Not the same as out of network.
Office
1

Offices

1 location · Lpch Medical Group Div of Lucile · 332 clinicians in this group

Looking this up.

Hospitals listed: Lucile Salter Packard Children'S Hsp at Stanford. That is not proof they admit you there this week.

Plan participation

Not verified

We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Wong’s office at (650) 498-7200 to ask if they take your plan before you enroll.

California Medical Board record

Licence A91426 · Current

Licensed to practise in California · since 2005 · expires 2027-05-31 · University of Washington School of Medicine.

No disciplinary actions, convictions, malpractice judgments or citations in this record.

Hospitals they work in

1 hospital

These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.

  • Lucile Salter Packard Children'S Hsp at StanfordPalo Alto, CAChildren · Voluntary non-profit - Private · No emergency departmentPart of Stanford Health Care, which runs 3 hospitals
    No overall ratingNo measure marked better or worse than the national rate

Original Medicare doctor bills

$15,688

Medicare paid this office $15,688 for 12 people.

This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.

Who their Medicare patients are

12 Original Medicare patients in 2024. Average age 14 · Under 65 100% · 85 and older 0% · Health risk score 7.71. Sicker patients than 9 in 10 peers; the typical nephrology clinician is at 4.01.

Conditions among them: Chronic kidney disease 75%.

The office billed $60,344, Medicare allowed $19,691 and paid $15,688; for 88 services of 13 kinds.

Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.

Year by year

Original Medicare by year
20241288147.71$60,344$15,688
20221139146.59$38,428$10,448
20211480117.32$59,246$16,357
20191332134.02$31,570$8,289
20181747134.69$27,647$7,175
20172287126.88$57,319$15,347
20162299137.09$54,910$16,615
20151895146.82$86,406$24,910
20141777134.77$60,817$17,977
201320136123.90$60,340$15,068

Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.

See the services billed each year

2017: 1 service

Original Medicare services billed in 2017
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes13$4,211$86

2013: 1 service

Original Medicare services billed in 2013
Long return visit (40+ min)11$880$68

Medicaid work

$11,269 in 2024

Medicaid paid $11,269 for 79 billed services this clinician did in 2024, up to 18 people in a month for one service.

Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.

Largest Medicaid services in 2024
Long return visit (40+ min)48$8,983
SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES31$2,286
Medicaid work by year
202479218$11,269
2023142223$18,251
2022203220$21,284
2021245224$24,811
202049117$6,589
2019267221$24,410
201869120$8,166
See the largest Medicaid services in earlier years

2023

Largest Medicaid services in 2023
Long return visit (40+ min)91$13,884
SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES51$4,368

2022

Largest Medicaid services in 2022
Long return visit (40+ min)83$12,147
SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES120$9,138

2021

Largest Medicaid services in 2021
Long return visit (40+ min)98$13,896
SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES147$10,914

2020

Largest Medicaid services in 2020
Long return visit (40+ min)49$6,589

2019

Largest Medicaid services in 2019
Long return visit (40+ min)110$13,948
SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES157$10,462

2018

Largest Medicaid services in 2018
Long return visit (40+ min)69$8,166

Money from drug and device companies

$108 in 2025

Industry payments by year
202513None$108
202411None$123
202312None$83
202211None$122
201911None$122

Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.

A payment is not proof that care is biased.

Payments by company
Abbott LaboratoriesNone$108
3 payments
  • Meals · 2025-09-11 · $34
  • Meals · 2025-07-23 · $39
  • Meals · 2025-04-08 · $35
See all 3 published payments
Every published payment
Abbott LaboratoriesMeals · 2025-09-11None$34
Abbott LaboratoriesMeals · 2025-07-23None$39
Abbott LaboratoriesMeals · 2025-04-08None$35
See earlier years (2024, 2023, 2022, 2019)

2024: $123

Payments by company in 2024
NuwellisAquadex Smartflow Console$123
1 payment
  • Meals for Aquadex Smartflow Console · 2024-04-03 · $123

2023: $83

Payments by company in 2023
PenumbraRuby Coil$83
2 payments
  • Meals for Penumbra System · 2023-11-08 · $17
  • Meals for Ruby Coil · 2023-07-10 · $66

2022: $122

Payments by company in 2022
Alexion PharmaceuticalsUltomiris$122
1 payment
  • Meals for Ultomiris · 2022-10-26 · $122

2019: $122

Payments by company in 2019
Alexion PharmaceuticalsNone$122
1 payment
  • Meals · 2019-06-24 · $122

Research money

Money a company paid to run a study. Where it went to their institution, the clinician is named as an investigator and did not receive it; the amount covers the whole study, often across many sites.

Research payments by company and study
AKEBIA THERAPEUTICS INC · A 36-Week, Single-Arm, Open-Label Study To Evaluate the Safety and Tolerability of Ferric Citrate in Children With Hyperphosphatemia Related To Chronic Kidney Disease · 2023Their institution$39,584
AKEBIA THERAPEUTICS INC · A 36-Week, Single-Arm, Open-Label Study To Evaluate the Safety and Tolerability of Ferric Citrate in Children With Hyperphosphatemia Related To Chronic Kidney Disease · 2024Their institution$24,309
AKEBIA THERAPEUTICS INC · A 36-Week, Single-Arm, Open-Label Study To Evaluate the Safety and Tolerability of Ferric Citrate in Children With Hyperphosphatemia Related To Chronic Kidney Disease · 2025Their institution$8,380
RELYPSA, INC. · Emerald · 2020Their institution$2,220
Vifor Pharma, Inc. · Emerald · 2022Their institution$1,280

Professional record

NPI
1841214376
Licence
CA A91426California A91426: Current · expires 2027-05-31
Trained
University of Washington School of Medicine, 1999
Gender
Female
More record details
Sole proprietor
No
Taxonomy
Federal specialty code 2080P0210X (2080P0210X)
Mailing address
300 Pasteur Drive, G306, Stanford, CA, 94305
NPI first listed
2006-07-27
NPI last updated
2007-07-08

This is when the NPI record was last certified, not a medical board exam.